APA Alıntı

Lu, M., Wang, X., Shen, L., Jia, J., Gong, J., Li, J., . . . Zhang, X. (2016). Nimotuzumab plus paclitaxel and cisplatin as the first line treatment for advanced esophageal squamous cell cancer: A single centre prospective phase II trial. Cancer Sci.

Chicago Stili Alıntı

Lu, Ming, et al. "Nimotuzumab Plus Paclitaxel and Cisplatin As the First Line Treatment for Advanced Esophageal Squamous Cell Cancer: A Single Centre Prospective Phase II Trial." Cancer Sci 2016.

MLA Alıntı

Lu, Ming, et al. "Nimotuzumab Plus Paclitaxel and Cisplatin As the First Line Treatment for Advanced Esophageal Squamous Cell Cancer: A Single Centre Prospective Phase II Trial." Cancer Sci 2016.